Definitions
from Wiktionary, Creative Commons Attribution/Share-Alike License.
- noun A type of
erythropoietin used to treat patients suffering fromanemia caused by chronic kidney disease
Etymologies
Sorry, no etymologies found.
Support
Help support Wordnik (and make this page ad-free) by adopting the word epoetin.
Examples
-
Anemia drugs, known as erythropoiesis-stimulating agents (ESAs), such as epoetin alfa (Epogen) and darbepoetin alfa (Aranesp), stimulate red blood cell production and are intended to reduce the number of blood transfusions required during chemotherapy.
-
Anemia drugs, known as erythropoiesis-stimulating agents (ESAs), such as epoetin alfa (Epogen) and darbepoetin alfa (Aranesp), stimulate red blood cell production and are intended to reduce the number of blood transfusions required during chemotherapy.
-
This results in a reduced frequency of doses, providing a simpler and more convenient treatment option for patients and physicians as compared to treatment of anemia with epoetin which is the current standard of care in India.
THE MEDICAL NEWS 2010
-
PRCA is a rare, serious and debilitating autoimmune disorder, which can occur when the body produces neutralizing antibodies against the currently marketed recombinant human erythropoietins, such as epoetin alfa or beta and darbepoetin alfa, thus suppressing the production of red blood cells by the bone marrow.
-
Both drugs are the same product, epoetin alfa, which Amgen makes and markets as Epogen for kidney-failure patients on dialysis, and has licensed other uses to J & J, which sells it as Procrit.
Corporate Watch 2010
-
In fact, in June 2009 we raised the red flag around safety concerns associated with the anemia drugs epoetin alfa (Epogen and Procrit) and darbepoetin alfa (Aranesp) which are both huge-sellers in the U.S.
Reevaluate this: Drugs to boost hemoglobin need better research 2010
-
In fact, in June 2009 we raised the red flag around safety concerns associated with the anemia drugs epoetin alfa (Epogen and Procrit) and darbepoetin alfa (Aranesp) which are both huge-sellers in the U.S.
Reevaluate this: Drugs to boost hemoglobin need better research 2010
-
In 2008, the Food and Drug Administration issued a black-box warning on darbepoetin alfa and epoetin alfa, and suggested limiting the use of ESAs to specific tumor types, durations, and targeted hemoglobin levels.
-
In 2008, the Food and Drug Administration issued a black-box warning on darbepoetin alfa and epoetin alfa, and suggested limiting the use of ESAs to specific tumor types, durations, and targeted hemoglobin levels.
-
The out-of-competition testing began in mid-February, with a particular focus on two drugs — epoetin and darbepoetin.
California racetracks conduct out-of-competition drug testing 2007
Comments
Log in or sign up to get involved in the conversation. It's quick and easy.